InvestorsHub Logo
Followers 44
Posts 10455
Boards Moderated 0
Alias Born 01/13/2016

Re: jimmy667 post# 66979

Wednesday, 07/06/2016 9:19:58 AM

Wednesday, July 06, 2016 9:19:58 AM

Post# of 462742
Jimmy, thanks! sometimes Value is in the eye of the beholder. I don't know how much simpler the evidence can be made, that A2-73 is a symptomatic curative treatment. But even some people that are witness to A2-73's effects first hand have a difficult time because they have not spent 10 years of their life watching a loved one die from Alzheimers.
Progression in Alzheimers is relentless and terribly wicked. I cry thinking of my Dad and his caregiver(my Mom). To have a chance at a A3-72! oh just to have a chance at it!
AND what if..a Neuren or another drug multiplies the effect of A2-73? They are taling about another YEAR for Anavex..FORGET IT! WE WANT ANAVEX NOW!
If this were cancer..and 80% of a population were in remission..
and there were ZERO SAFETY alarms..Do YOU THINK it would be another YEAR?
NO it would not! It would be Breakthrough, Compassionate Care..get it to them,,tehy are dying..
WHY ISN'T ALZHEIMERS treated teh same way? Cause it takes longer? BS!
The higher teh Value fo Anavex teh QUICKER A2-73 gets to market. The Company should not manage for that..but WE OWNERS SHOULD!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News